223 related articles for article (PubMed ID: 17916760)
1. Pharmacological characterization of indacaterol, a novel once daily inhaled 2 adrenoceptor agonist, on small airways in human and rat precision-cut lung slices.
Sturton RG; Trifilieff A; Nicholson AG; Barnes PJ
J Pharmacol Exp Ther; 2008 Jan; 324(1):270-5. PubMed ID: 17916760
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo pharmacological characterization of 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one (indacaterol), a novel inhaled beta(2) adrenoceptor agonist with a 24-h duration of action.
Battram C; Charlton SJ; Cuenoud B; Dowling MR; Fairhurst RA; Farr D; Fozard JR; Leighton-Davies JR; Lewis CA; McEvoy L; Turner RJ; Trifilieff A
J Pharmacol Exp Ther; 2006 May; 317(2):762-70. PubMed ID: 16434564
[TBL] [Abstract][Full Text] [Related]
3. Effect of indacaterol, a novel long-acting beta2-agonist, on isolated human bronchi.
Naline E; Trifilieff A; Fairhurst RA; Advenier C; Molimard M
Eur Respir J; 2007 Mar; 29(3):575-81. PubMed ID: 17135231
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological characterization of abediterol, a novel inhaled β(2)-adrenoceptor agonist with long duration of action and a favorable safety profile in preclinical models.
Aparici M; Gómez-Angelats M; Vilella D; Otal R; Carcasona C; Viñals M; Ramos I; Gavaldà A; De Alba J; Gras J; Cortijo J; Morcillo E; Puig C; Ryder H; Beleta J; Miralpeix M
J Pharmacol Exp Ther; 2012 Aug; 342(2):497-509. PubMed ID: 22588259
[TBL] [Abstract][Full Text] [Related]
5. Formoterol and salmeterol induce a similar degree of β2-adrenoceptor tolerance in human small airways but via different mechanisms.
Cooper PR; Kurten RC; Zhang J; Nicholls DJ; Dainty IA; Panettieri RA
Br J Pharmacol; 2011 Jun; 163(3):521-32. PubMed ID: 21306583
[TBL] [Abstract][Full Text] [Related]
6. Functional and binding characteristics of long-acting beta 2-agonists in lung and heart.
Roux FJ; Grandordy B; Douglas JS
Am J Respir Crit Care Med; 1996 May; 153(5):1489-95. PubMed ID: 8630591
[TBL] [Abstract][Full Text] [Related]
7. Duration of action of inhaled vs. Intravenous beta(2)-adrenoceptor agonists in an anaesthetized guinea-pig model.
Mohammed SP; Taylor CV; Weyman-Jones CB; Mather ME; Vendy K; Dougall IG; Young A
Pulm Pharmacol Ther; 2000; 13(6):287-92. PubMed ID: 11061983
[TBL] [Abstract][Full Text] [Related]
8. Profiling the bronchodilator effects of the novel ultra-long-acting β2-agonist indacaterol against established treatments in chronic obstructive pulmonary disease.
Vogelmeier C; Magnussen H; LaForce C; Owen R; Kramer B
Ther Adv Respir Dis; 2011 Oct; 5(5):345-57. PubMed ID: 21719531
[TBL] [Abstract][Full Text] [Related]
9. Systemic administration of beta2-adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses.
Ryall JG; Sillence MN; Lynch GS
Br J Pharmacol; 2006 Mar; 147(6):587-95. PubMed ID: 16432501
[TBL] [Abstract][Full Text] [Related]
10. [Indacaterol--a new hope for maximising bronchodilation?].
Mihălţan F
Pneumologia; 2011; 60(1):21-5. PubMed ID: 21548196
[TBL] [Abstract][Full Text] [Related]
11. Relaxant effects and durations of action of formoterol and salmeterol on the isolated human bronchus.
Naline E; Zhang Y; Qian Y; Mairon N; Anderson GP; Grandordy B; Advenier C
Eur Respir J; 1994 May; 7(5):914-20. PubMed ID: 7914176
[TBL] [Abstract][Full Text] [Related]
12. Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparison.
Kornmann O; Dahl R; Centanni S; Dogra A; Owen R; Lassen C; Kramer B;
Eur Respir J; 2011 Feb; 37(2):273-9. PubMed ID: 20693243
[TBL] [Abstract][Full Text] [Related]
13. Lipid membrane interactions of indacaterol and salmeterol: do they influence their pharmacological properties?
Lombardi D; Cuenoud B; Krämer SD
Eur J Pharm Sci; 2009 Dec; 38(5):533-47. PubMed ID: 19819331
[TBL] [Abstract][Full Text] [Related]
14. In vivo effect of albuterol on methacholine-contracted bronchi in conjunction with salmeterol and formoterol.
Aziz I; Lipworth BJ
J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):816-22. PubMed ID: 10329815
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological basis for duration of effect: formoterol and salmeterol versus short-acting beta 2-adrenoceptor agonists.
Lindén A; Rabe KF; Löfdahl CG
Lung; 1996; 174(1):1-22. PubMed ID: 8746998
[TBL] [Abstract][Full Text] [Related]
16. Kinetic analysis of drug-receptor interactions of long-acting beta2 sympathomimetics in isolated receptor membranes: evidence against prolonged effects of salmeterol and formoterol on receptor-coupled adenylyl cyclase.
Teschemacher A; Lemoine H
J Pharmacol Exp Ther; 1999 Mar; 288(3):1084-92. PubMed ID: 10027845
[TBL] [Abstract][Full Text] [Related]
17. Onset of action of indacaterol in patients with COPD: comparison with salbutamol and salmeterol-fluticasone.
Balint B; Watz H; Amos C; Owen R; Higgins M; Kramer B;
Int J Chron Obstruct Pulmon Dis; 2010 Sep; 5():311-8. PubMed ID: 20856830
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of indacaterol 75 μg once daily in patients aged ≥40 years with chronic obstructive pulmonary disease: results from 2 double-blind, placebo-controlled 12-week studies.
Kerwin EM; Gotfried MH; Lawrence D; Lassen C; Kramer B
Clin Ther; 2011 Dec; 33(12):1974-84. PubMed ID: 22177371
[TBL] [Abstract][Full Text] [Related]
19. The identification of indacaterol as an ultralong-acting inhaled beta2-adrenoceptor agonist.
Baur F; Beattie D; Beer D; Bentley D; Bradley M; Bruce I; Charlton SJ; Cuenoud B; Ernst R; Fairhurst RA; Faller B; Farr D; Keller T; Fozard JR; Fullerton J; Garman S; Hatto J; Hayden C; He H; Howes C; Janus D; Jiang Z; Lewis C; Loeuillet-Ritzler F; Moser H; Reilly J; Steward A; Sykes D; Tedaldi L; Trifilieff A; Tweed M; Watson S; Wissler E; Wyss D
J Med Chem; 2010 May; 53(9):3675-84. PubMed ID: 20402514
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological similarities and differences between beta2-agonists.
Lötvall J
Respir Med; 2001 Aug; 95 Suppl B():S7-11. PubMed ID: 11534896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
